|
|
| Research article summary (published 6 Sep 2009): |
Epigenetic loss of mucosa-associated lymphoid tissue 1 expression in patients with oral carcinomas.
Full Abstract
Mucosa-associated lymphoid tissue 1 (MALT1), which is located in a genomic region that encodes unknown tumor suppressor gene(s), activates nuclear factor-kappaB in lymphocyte lineages. However, its expression and role in the pathology of malignant tumors of epithelial origin is not known. In the present study, we examined MALT1 expression and its implications for the pathology of oral carcinomas. Immunostaining localized MALT1 in the nucleus of normal oral epithelial cells, but the expression was absent in 45.0% of carcinomas (49 of 109 cases) especially at the invasive front. The loss of expression was correlated with tumor recurrence (P = 0.007) and poor patient survival (P < 0.001), and it was an independent prognostic determinant (P < 0.001). MALT1-negative carcinomas exhibited microsatellite instability at the MALT1 locus and a specific cytosine methylation positioned at -256 from the gene, and the expression was recovered by demethylation treatment. In contrast to lymphocyte lineages, carcinoma cells showed MALT1 located at the nucleus independent of its domain structures, and its loss of expression induced the epithelial-mesenchymal transition. These results show that MALT1 is expressed in the nucleus of oral epithelial cells and that its expression is epigenetically inactivated during tumor progression, suggesting that the detection of MALT1 expression is a useful predictive and prognostic determinant in the clinical management of oral carcinomas.
Author information
Author/s: Chiba, Tadashige (T); Maeda, Genta (G); Kawashiri, Shuichi (S); Kato, Koroku (K); Imai, Kazushi (K);
Affiliation: Department of Biochemistry, School of Life Dentistry at Tokyo, The Nippon Dental University, Chiyoda-ku, Tokyo, Japan.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Cancer research (Cancer Res), published in United States. (Language: eng)
Reference: 2009-Sep; vol 69 (issue 18) : pp 7216-23
Dates: Created 2009/09/16; Completed 2009/10/07;
PMID: 19738055, status: MEDLINE (last retrieved date: 10/7/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Neoplasm Proteins (0) ; Caspases (EC 3.4.22.-) ; MALT1 protein, human (EC 3.4.22.-)Related articles
These are the most related articles currently in our database:
- Urokinase gene 3'-UTR T/C polymorphism is associated with oral cancer.
30 Dec 2003 - Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma.
29 Apr 2007 - Telomerase activity in oral cancer.
29 Apr 1999 - Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer.
29 Jun 2002 - [Telomerase hTRT mRNA expression in oral squamous cell carcinogenesis]
30 Oct 1999 - [Localized observations of superoxide dismutase by immunohistochemistry in oral squamous cell carcinoma tissues]
27 Feb 1995 - Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.
29 Jun 2007 - Telomerase activity in oral squamous cell carcinoma.
29 Jun 1998 - High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
29 Jun 2007 - Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma.
30 Dec 2004
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.